Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

This publication has 41 references indexed in Scilit:

• Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
  New England Journal of Medicine, 2006
• Beware the meta-analysis — clozapine and suicidal ideation
  Schizophrenia Research, 2006
• Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease
  American Heart Journal, 2005
• Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings
  American Journal of Kidney Diseases, 2004
• Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis
  Kidney International, 2004
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Normalizing hematocrit in dialysis patients improves brain function
  American Journal of Kidney Diseases, 1999
• Coagulation Studies and Fistula Blood Flow During Erythropoietin Therapy in Haemodialysis Patients
  Nephrology Dialysis Transplantation, 1991
• Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
  BMJ, 1990
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986